All In MedTech

FDA Clearance Tracker · P840024-S084

NUCLEUS 22 COCHLEAR IMPLANT SYSTEM FOR ADULTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 9, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 9, 2002

Approved

Time to decision

39 days

Received Oct 31, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P840024-S084
Device name
NUCLEUS 22 COCHLEAR IMPLANT SYSTEM FOR ADULTS
Applicant location
Lone Tree, CO
Received
Oct 31, 2002
Decided
Dec 9, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P840024

Device type

Device class
Class III

Every decision under product code MCM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR EXPANSION OF THE MANUFACTURING FACILITY LOCATED AT COCHLEAR LIMITED, LANE COVE, AUSTRALIA.

Source documents

Other decisions for Cochlear Americas

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.